The National Heart, Lung, and Blood Institute (NHLBI) has paused a clinical trial testing an experimental stem cell therapy in heart failure patients. NHLBI paused the study because of recommendations to retract 31 journal articles from the lab of a controversial cardiac stem cell researcher in related fields of cell therapy research, which raised concerns about the scientific foundations of this trial. (STAT)